Lisdexamfetamine Dimesylate Tablet, Chewable shortage
Lisdexamfetamine Dimesylate Tablet, Chewable is currently listed in shortage by the FDA. The FDA lists 18 affected products. This page was last refreshed from FDA data on Oct 4, 2026.
Vyvanse (lisdexamfetamine) chewable tablets are on the FDA shortage list, though all strengths still have at least some supply from manufacturers that reported the shortage. Other makers — SpecGx and Teva — also list chewable lisdexamfetamine tablets at several strengths without reporting a shortage.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Lisdexamfetamine Dimesylate Tablet, Chewable. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 18, 2026Currently in shortage18 of 18 products affected.
-
Sep 16, 2026FDA refreshed this shortage record6 products updated.
-
Sep 15, 2026FDA refreshed this shortage record6 products updated.
-
Jul 14, 2023First reported to the FDA18 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Novadoz Pharmaceuticals LLC 📞 (855) 668-2369; [email protected] 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) | — | Available | — | — |
Manufacturer: Sun Pharmaceutical Industries, Inc. 📞 800-818-4555 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | — | Available | — | — |
Manufacturer: Takeda Pharmaceuticals USA Inc. 📞 877-TAKEDA-7 (1-877-825-3327) 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) | — | Available | — | — |
| Current | Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) | — | Available | — | — |
| Current | Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) | — | Available | — | — |
| Current | Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) | — | Available | — | — |
| Current | Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) | — | Available | — | — |
| Current | Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Lisdexamfetamine Dimesylate Tablet, Chewable — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Lisdexamfetamine Dimesylate Tablet, Chewable? options further down this page.
Why is Lisdexamfetamine Dimesylate Tablet, Chewable in shortage?
The FDA has this chewable lisdexamfetamine tablet on its shortage list, but none of the manufacturers reported here — Novadoz Pharmaceuticals, Takeda Pharmaceuticals (Vyvanse), or Sun Pharmaceutical Industries — shared a specific public reason for why it's on the list. The FDA's data simply doesn't include an explanation in this case.
What I can tell you is that all three of these manufacturers are currently showing their products as available across all strengths (10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg). So while the shortage status is officially listed as current, no specific cause — like a factory delay or a big jump in demand — was disclosed in this report.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Lisdexamfetamine Dimesylate Tablet, Chewable, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Lisdexamfetamine Dimesylate Tablet, Chewable?
Lisdexamfetamine dimesylate chewable tablets (the chewable form of Vyvanse and its generics) are currently listed on the FDA drug-shortage page. Seeing your medicine on that list is understandable cause for concern, so let me walk you through where things actually stand.
Here is the reassuring part: every strength is still reporting an available source. The 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg chewable tablets all have supply right now, and none are listed as unavailable. All three manufacturers on this record are still reporting stock.
This shortage has been on the books for over a year, but the overall supply risk is rated low. A listing like this often means supply is tight or uneven across the country rather than gone — which is why your local pharmacy's shelf may not always match this national data.
What you can do:
- Do not stop, skip, or change your dose on your own.
- If your pharmacy is short, ask them to order your strength; they can check wholesalers and all three makers (Novadoz, Takeda/Vyvanse, and Sun).
- The same medicine is also made by SpecGx and Teva — your pharmacy may be able to source one of these, though it may not be in local stock.
- If your exact tablet cannot be found, ask your prescriber or pharmacist about options.
Manufacturer contact numbers are listed on this page for reference, though pharmacies usually handle those calls. This is general, national information and may not match your pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
- This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Lisdexamfetamine Dimesylate Tablet, Chewable?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Lisdexamfetamine Dimesylate Tablet, Chewable is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 10 mg/1 | Tablet, Chewable · Oral | SpecGx LLC | 00406-5124-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 20 mg/1 | Tablet, Chewable · Oral | SpecGx LLC | 00406-5125-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 30 mg/1 | Tablet, Chewable · Oral | SpecGx LLC | 00406-5126-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 40 mg/1 | Tablet, Chewable · Oral | SpecGx LLC | 00406-5127-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 50 mg/1 | Tablet, Chewable · Oral | SpecGx LLC | 00406-5128-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 60 mg/1 | Tablet, Chewable · Oral | SpecGx LLC | 00406-5129-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 10 mg/1 | Tablet, Chewable · Oral | Teva Pharmaceuticals, Inc. | 00480-9737-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 20 mg/1 | Tablet, Chewable · Oral | Teva Pharmaceuticals, Inc. | 00480-9738-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 30 mg/1 | Tablet, Chewable · Oral | Teva Pharmaceuticals, Inc. | 00480-9739-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 40 mg/1 | Tablet, Chewable · Oral | Teva Pharmaceuticals, Inc. | 00480-9741-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 50 mg/1 | Tablet, Chewable · Oral | Teva Pharmaceuticals, Inc. | 00480-9742-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 60 mg/1 | Tablet, Chewable · Oral | Teva Pharmaceuticals, Inc. | 00480-9744-01 |
Alternative dosage forms of Lisdexamfetamine Dimesylate
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 21 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Lisdexamfetamine Dimesylate 50 mg | SpecGx | 100 tablets | $3.649 | AB | Availability likely |
| lisdexamfetamine dimesylate 50 mg | Teva | 100 tablets | $3.649 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 50 mg | Camber | 100 tablets | $3.649 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 50 mg | Sun | 100 tablets | $3.649 | AB | Availability likely |
| Lisdexamfetamine dimesylate 50 mg | Granules | 100 tablets | $3.649 | AB | Availability likely |
| Lisdexamfetamine dimesylate 50 mg | Novadoz | 100 tablets | $3.649 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | SpecGx | 100 tablets | $3.981 | AB | Availability likely |
| lisdexamfetamine dimesylate 40 mg | Teva | 100 tablets | $3.981 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Camber | 100 tablets | $3.981 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Sun | 100 tablets | $3.981 | AB | Availability likely |
| Lisdexamfetamine dimesylate 40 mg | Granules | 100 tablets | $3.981 | AB | Availability likely |
| Lisdexamfetamine dimesylate 40 mg | Novadoz | 100 tablets | $3.981 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | SpecGx | 100 tablets | $4.338 | AB | Availability likely |
| lisdexamfetamine dimesylate 20 mg | Teva | 100 tablets | $4.338 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Camber | 100 tablets | $4.338 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Sun | 100 tablets | $4.338 | AB | Availability likely |
| Lisdexamfetamine dimesylate 20 mg | Granules | 100 tablets | $4.338 | AB | Availability likely |
| Lisdexamfetamine dimesylate 20 mg | Novadoz | 100 tablets | $4.338 | AB | Availability likely |
| Vyvanse 20 mg | Takeda | 100 tablets | $12.350 | AB | Availability likely |
| Vyvanse 40 mg | Takeda | 100 tablets | $12.357 | AB | Availability likely |
| Vyvanse 50 mg | Takeda | 100 tablets | $12.358 | AB | Availability likely |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Lisdexamfetamine Dimesylate Tablet, Chewable — that fall in the same broad treatment class (adrenergics, aromatic, non-catecholamine) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other psychiatry shortages
Lisdexamfetamine Dimesylate Tablet, Chewable shortage FAQs
Is Lisdexamfetamine Dimesylate Tablet, Chewable in shortage?
Which products are affected?
When will Lisdexamfetamine Dimesylate Tablet, Chewable be available again?
Can I still get Lisdexamfetamine Dimesylate somewhere?
What should I do if I take Lisdexamfetamine Dimesylate Tablet, Chewable?
Still have a question about the Lisdexamfetamine Dimesylate Tablet, Chewable shortage?
Ask a pharmacist about this shortage →View Lisdexamfetamine Dimesylate Tablet, Chew... on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.